Macrophages are novel sites of expression and regulation of retinol binding protein-4 (RBP4)

Physiological Research

Volumn 59, Issue 2, 2010, Pages 299-303

  Broch, M ^a,d   Ramirez R ^b   Auguet, M T ^a,b,d   Alcaide, M J ^b   Aguilar, C ^a,d   Garcia Espana A ^c   Richart, C ^a,b,d  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

^c INSTITUT D INVESTIGACIÓ SANITÀRIA PERE VIRGILI IISPV   (Spain)

^d UNIVERSITAT ROVIRA I VIRGILI   (Spain)

Author keywords

Inflammatory markers; Obesity; Primary human macrophages; RBP4

Indexed keywords

IL6 PROTEIN, HUMAN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; PLASMA RETINOL BINDING PROTEIN; RBP4 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL CULTURE; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION; GENETICS; HUMAN; IMMUNOLOGY; MACROPHAGE; METABOLISM; OBESITY;

CELLS, CULTURED; GENE EXPRESSION; HUMANS; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MACROPHAGES; OBESITY; RETINOL-BINDING PROTEINS, PLASMA; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77953942084     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. ARKAN MC, HEVENER AL, GRETEN FR, MAEDA S, LI Z, LONG JM, WYNSHAW-BORIS A, POLI G, OLEFSKY J: IKK-β links inflammation to obesity-induced insulin resistance. Nat Med 11: 191-198, 2005.
2. BALAGOPAL P, GRAHAM TE, KAHN BB, ALTOMARE A, FUNANAGE V, GEORGE D: Reduction of elevated serum retinol binding protein (RBP4) in obese children by lifestyle intervention: association with subclinical inflammation. J Clin Endocrinol Metab 92: 1971-1974, 2007.
3. ENDEMANN G, STANTON LW, MADDEN KS, BRYANT CM, WHITE RT, PROTTER AA: CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem 268: 11811-11816, 1993.
4. HAMMARSTEDT A, PIHLAJAMÄKI J, GRAHAM TE, KAINULAINEN S, KAHN BB, LAAKSO M, SMITH U: High circulating levels of RBP4 and mRNA levels of aP2, PGC-1α and UCP-2 predict improvement in insulin sensitivity following pioglitazone treatment of drug-naive type diabetic subjects. J Intern Med 263: 440-449, 2008.
5. HOLMESS CL, SIMMONS DL: Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins. Blood 81: 1607-1613, 1993.
6. JANKE J, ENGELI S, BOSCHMANN M, ADAMS F, BÖHNKE J, LUFT FC, SHARMA AM, JORDAN J: Retinolbinding protein in human obesity. Diabetes 55: 2805-2810, 2006.
7. KLÖTING N, GRAHAM TE, BERNDT J, KRALISCH S, KOVACS P, WASON CJ, FASSHAUER M, SCHÖN MR, STUMVOLL M, BLÜHER M, KAHN BB: Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass. Cell Metab 6: 79-87, 2007.
8. LEE CH, EVANS RM: Peroxisome proliferator-activated receptor-(in macrophage lipid homeostasis. Trends Endocrinol Metab 13: 331-335, 2002.
9. LEHRKE M, REILLY MP, MILLINGTON SC, IQBAL N, RADER DJ, LAZAR MA: An inflammatory cascade leading to hyperresistinemia in humans. PLoS Med 1: 191-197, 2007.
10. LIN KD, CHANG YH, WANG CL, YANG YH, HSIAO PJ, LI TH, SHIN SJ: Thiazolidinedione addition reduces the serum retinol-binding protein 4 in type 2 diabetic patients treated with metformin and sulfonylurea. Transl Res 151: 309-314, 2008.
11. LINTON MF, FAZIO S: Macrophages, inflammation, and atherosclerosis. Int J Obes Relat Metab Disord 27: S35-S40, 2003.
12. MAKOWSKI L, BOORD JB, MAEDA K, BABAEV VR, UYSAL KT, MORGAN MA, PARKER RA, SUTTLES J, FAZIOS S, HOTAMISLIGIL GS, LINTON MF: Lack of macrophage fatty-acid binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nat Med 7: 699-705, 2001.
13. MRÁČEK T, CANNON B, HOUŠTĚK J: IL-1 and LPS but not IL-6 inhibit differentiation and downregulate PPARγ in brown adipocytes. Cytokine 26: 9-15, 2004.
14. PATEL L, BUCKELS AC, KINGHORN IJ, MURDOCK PR, HOLBROOK JD, PLUMPTON CH, MACPHEE CH, SMITH SA: Resistin is expressed in human macrophages and directly regulated by PPARγ activators. Biochem Biophys Res Commun 300: 472-476, 2003.
15. SELL H, ECKEL J: Regulation of retinol binding protein 4 production in primary human adipocytes by adiponectin, troglitazone and TNF-α. Diabetologia 50: 2221-2223, 2007.
16. SHANSHAN P, YINGYING L. Role of resistin in inflammation and inflammation-related diseases. Cell Mol Immunol 3: 29-34, 2006.
17. TESZ GJ, GUILHERME A, GUNTUR KV, HUBBARD AC, TANG X, CHAWLA A, CZECH MP. Tumor necrosis factor α (TNFα) stimulates Map4k4 expression through TNFα receptor 1 signaling to c-Jun and activating transcription factor 2. J Biol Chem 282: 19302-19312, 2007.
18. VOSPER H, PATEL L, GRAHAM TL, KHOUDOLI GA, HILL A, MACPHEE CH, PINTO I, SMITH SA, SUCKLING KE, WOLF CR, PALMER CNA. The peroxisome proliferator-activated receptor γ promotes lipid accumulation in human macrophages. J Biol Chem 23: 44258-44265, 2001.
19. WEIBIN X, LU Y, WENZHONG Z, MIN L. Resistin increases lipid accumulation and CD36 expression in human macrophages. Biochem Biophys Res Commun 351: 376-382, 2006.
20. WEISBERG SP, MCCANN D, DESAI M, ROSENBAUM M, LEIBLE RL, FERRANTE JR AW. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112: 1796-1808, 2003.
21. YANG Q, GRAHAM TE, MODY N, PREITNER F, PERONI OD, ZABOLOTNY JM, KOTANI K, QUADROL L, KAHN BB. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 436: 356-362, 2005.
22. YAO-BORENGASSER A, VARMA V, BODLES AM, RASOULI N, PHANAVANH B, LEE MJ, STARKS T, KERN LM, SPENCER HJ, RASHIDI AA, MCGEHEE RE, FRIED SK, KERN PA. Retinol binding protein 4 expression in humans. Relationship to insulin resistance, inflammation, and response to pioglitazone. J Clin Endocrinol Metab 92: 2590-2597, 2007.
23. ZHANG B, BERGER J, HU E, SZALKOWSKI D, WHITE-CARRINGTON S, SPIEGELMAN BM, MOLLER DE. Negative regulation of peroxisome proliferator-activated receptor-gamma gene expression contributes to the antiadipogenic effects of tumor necrosis factor-alpha. Mol Endocrinol 10: 1457-1466, 1996.